KALA BIO

$KALA BIO(KALA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001556257-25-000004  Size: 3 KB 网页链接

#药闻简讯# $KALA BIO(KALA)$ 宣布 CHASE 2b 期临床试验的顶线结果，评估 KPI-012 治疗持续性角膜上皮缺损（PCED）的效果，未达到主要终点。#临床研究失败#

$KALA BIO(KALA)$ 眼药二期试验失败，中止开发并裁员，今夜开盘暴跌92%。见证创新药的九死一生！#创新药#

纪念一下，个股暴跌90%$KALA BIO(KALA)$

$KALA BIO(KALA)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-096420  Act: 34  Size: 23 KB 网页链接

$KALA BIO(KALA)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008116  Act: 33  Size: 7 KB 网页链接

$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001710969-25-000003  Size: 6 KB 网页链接

$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001298079-25-000003  Size: 5 KB 网页链接

$KALA BIO(KALA)$ 8-K Current report, items 1.01, 2.03, 3.02, and 8.01 Accession Number: 0001104659-25-108844  Act: 34  Size: 152 KB 网页链接

$KALA BIO(KALA)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-25-112446  Act: 34  Size: 32 KB 网页链接

$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-25-003208  Size: 8 KB 网页链接

$KALA BIO(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001893729-25-000003  Size: 5 KB 网页链接

$KALA BIO(KALA)$ 8-K/A [Amend] Current report, items 2.05, 5.02, and 9.01 Accession Number: 0001104659-25-096071  Act: 34  Size: 225 KB 网页链接

$KALA BIO(KALA)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008125  Act: 33  Size: 5 KB 网页链接

$KALA BIO(KALA)$ 8-K Current report, item 2.04 Accession Number: 0001104659-25-095342  Act: 34  Size: 186 KB 网页链接

$KALA BIO(KALA)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-227218  Act: 34  Size: 606 KB 网页链接

$KALA BIO(KALA)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001829126-25-009711  Act: 33  Size: 551 KB 网页链接

$KALA BIO(KALA)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008117  Act: 33  Size: 5 KB 网页链接

$KALA BIO(KALA)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-008119  Act: 33  Size: 5 KB 网页链接

$KALA BIO(KALA)$ Baker Bros. Advisors LP 与 Baker Bros. Advisors (GP) LLC、Julian C. Baker、Felix J. Baker 就其在 KALA BIO, Inc. 的持股向 SEC 提交了 Schedule 13G。文件显示，报告人合计实益持有 744,759 股普通股，占已发行股份的 9.99%。其中包括由旗下基金直接持有的 E 系列优先股可...